Adverse effects of excessive leucine intake depend on dietary protein intake: A transcriptomic analysis to identify useful biomarkers

Journal of Nutritional Science and Vitaminology

Volumn 59, Issue 1, 2013, Pages 45-55

  Imamura, Wataru ^a   Yoshimura, Ryoji ^b   Takai, Marie ^b   Yamamura, Junki ^a   Kanamoto, Ryuhei ^b,c   Kato, Hisanori ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Biomarker; Dietary protein; DNA microarray; Leucine; Transcriptome

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; CYCLIN B2; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FIBROBLAST GROWTH FACTOR 21; INHIBIN; LEUCINE; RNA; SOMATOMEDIN BINDING PROTEIN 1; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GROWTH RETARDATION; LIVER WEIGHT; MALE; MARKER GENE; NONHUMAN; PROTEIN INTAKE; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL MARKERS; DIET; DIET, PROTEIN-RESTRICTED; DIETARY PROTEINS; DIETARY SUPPLEMENTS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY INTAKE; GENE EXPRESSION; GENETIC MARKERS; GROWTH; GROWTH DISORDERS; LEUCINE; LIVER; MALE; MICROARRAY ANALYSIS; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REGRESSION ANALYSIS; ROC CURVE; TRANSCRIPTOME;

RATTUS;

EID: 84875657503     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.59.45     Document Type: Article

References (34)

1. Deldicque L, Francaux M. 2008. Functional food for exercise performance: fact or foe? Curr Opin Clin Nutr Metab Care 11: 774-781.
2. Sauberlich HE. 1961. Studies on the toxicity and antagonism of amino acids for weanling rats. J Nutr 75: 61-72.
3. Edmonds MS, Baker DH. 1987. Amino acid excesses for young pigs: effects of excess methionine, tryptophan, threonine or leucine. JAnim Sci 64: 1664-1671.
4. Harper AE, Benevenga NJ, Wohlhueter RM. 1970. Effects of ingestion of disproportionate amounts of amino acids. Physiol Rev 50: 428-558.
5. Sunde RA, Thompson KM, Evenson JK, Thompson BM. 2009. Blood glutathione peroxidase-1 mRNA levels can be used as molecular biomarkers to determine dietary selenium requirements in rats. Exp Biol Med (Maywood) 234:1271-1279.
6. Lei XG, Evenson JK, Thompson KM, Sunde RA. 1995. Glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase are differentially regulated in rats by dietary selenium. J Nutr 125: 1438-1446.
7. Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, Kimball SR. 2000. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 130: 2413-2419.
8. Kadowaki M, Kanazawa T. 2003. Amino acids as regulators of proteolysis. J Nutr. 133: 2052S-2056S.
9. Smith TK, Austic RE. 1978. The branched-chain amino acid antagonism in chicks. J Nutr 108: 1180-1191.
10. Gatnau R, Zimmerman DR, Nissen SL, Wannemuehler M, Ewan RC. 1995. Effects of excess dietary leucine and leucine catabolites on growth and immune responses in weanling pigs. J Anim Sci 73: 159-165.
11. Kuhlman G, Roth JA, Flakoll PJ, Vandehaar MJ, Nissen S. 1988. Effects of dietary leucine, alpha-ketoisocapro-ate and isovalerate on antibody production and lymphocyte blastogenesis in growing lambs. J Nutr 118: 1564-1569.
12. Reeves PG, Rossow KL, Lindlauf J. 1993. Development and testing of the AIN-93 purified diets for rodents: results on growth, kidney calcification and bone mineralization in rats and mice. J Nutr 123: 1923-1931.
13. Saito K, Ohta Y, Sami M, Kanda T, Kato H. 2010. Effect of mild restriction of food intake on gene expression profile in the liver of young rats: reference data for in vivo nutrigenomics study. Br J Nutr 104: 941-950.
14. Akobeng AK. 2007. Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr 96: 644-647.
15. Fischer JE, Bachmann LM, Jaeschke R. 2003. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 29: 1043-1051.
16. Youden WJ. 1950. Index for rating diagnostic tests. Cancer 3: 32-35.
17. Perkins NJ, Schisterman EF. 2006. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 163: 670-675.
18. Aschkenasy A. 1979. Prevention of the immunodepres-sive effects of excess dietary leucine by isoleucine and valine in the rat. J Nutr 109: 1214-1222.
19. Calvert CC, Klasing KC, Austic RE. 1982. Involvement of food intake and amino acid catabolism in the branched-chain amino acid antagonism in chicks. J Nutr 112: 627-635.
20. Matsuzaki K, Kato H, Sakai R, Toue S, Amao M, Kimura T. 2005. Transcriptomics and metabolomics of dietary leucine excess. J Nutr 135: 1571S-1575S.
21. Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34.
22. Silha JV, Murphy LJ. 2002. Insights from insulin-like growth factor binding protein transgenic mice. Endocrinology 143: 3711-3714.
23. Takenaka A, Hirosawa M, Mori M, Yamada S, Miura Y, Kato H, Takahashi S, Noguchi T. 1993. Effect of protein nutrition on the mRNA content of insulin-like growth factor-binding protein-1 in liver and kidney of rats. Br J Nutr 69: 73-82.
24. Filho JC, Hazel SJ, Anderstam B, Bergstrom J, Lewitt M, Hall K. 1999. Effect of protein intake on plasma and erythrocyte free amino acids and serum IGF-I and IGFBP-1 levels in rats. Am J Physiol 277: E693-701.
25. Averous J, Maurin AC, Bruhat A, Jousse C, Arliguie C, Fafournoux P. 2005. Induction of IGFBP-1 expression by amino acid deprivation of HepG2 human hepatoma cells involves both a transcriptional activation and an mRNA stabilization due to its 3'UTR. FEBS Lett 579: 2609-2614.
26. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB. 2005. FGF-21 as a novel metabolic regulator. J Clin Invest 115: 1627-1635.
27. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. 2008. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 8: 77-83.
28. Fisher FM, Estall JL, Adams AC, Antonellis PJ, Bina HA, Flier JS, Kharitonenkov A, Spiegelman BM, Maratos-Flier E. 2011. Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo. Endocrinology 152:2996-3004.
29. Cuevas-Ramos D, Almeda-Valdes P, Aguilar-Salinas CA, Cuevas-Ramos G, Cuevas-Sosa AA, Gomez-Perez FJ. 2009. The role of fibroblast growth factor 21 (FGF2l) on energy balance, glucose and lipid metabolism. Curr Diabetes Rev 5: 216-220.
30. Iizuka K, Takeda J, Horikawa Y. 2009. Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes. FEBS Lett 583: 2882-2886.
31. Lundasen T, Hunt MC, Nilsson LM, Sanyal S, Angelin B, Alexson SE, Rudling M. 2007. PPARalpha is a key regulator of hepatic FGF21. Biochem Biophys Res Commun 360: 437-440.
32. De Sousa-Coelho AL, Marrero PF, Haro D. 2012. Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation. Biochem J 443: 165-171.
33. Gerard C, Goldbeter A. 2009. Temporal self-organization of the cyclin/Cdk network driving the mammalian cell cycle. Proc Natl Acad Sci USA 106: 21643-21648.
34. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E. 1995. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6: 387-400.